FDA 'Entrepreneurs-In-Residence' Program Aims To Help Small Companies
This article was originally published in The Gray Sheet
Executive Summary
New FDA measures aimed at helping small businesses navigate the regulatory review process are part of the agency’s larger counter-attack against claims that it is creating a drag on medical product innovation.